Company Filing History:
9 out of 15 
4 out of 2,893 
Years Active: 2009-2022
Title: Innovations and Contributions of Inventor Xiao-Jun Ma
Introduction
Xiao-Jun Ma is a prominent inventor based in San Diego, CA, known for her significant contributions to the field of cancer research. With a total of 9 patents, her work focuses on the identification and classification of tumors through advanced gene expression measurements. Her innovative approaches have the potential to transform cancer diagnosis and treatment.
Latest Patents
Xiao-Jun Ma's latest patents include groundbreaking methods for the identification of tumors and tissues. This invention provides techniques for using gene expression measurements to classify or identify tumors in clinical samples, particularly in formalin-fixed, paraffin-embedded (FFPE) samples. Another notable patent addresses tumor grading and cancer prognosis. This disclosure includes the identification of gene expression profiles that correlate with tumor grade, offering a molecular index for determining tumor grade and predicting clinical outcomes. Additionally, her work encompasses methods for predicting cancer recurrence and the occurrence of metastatic cancer, which can guide treatment decisions based on life expectancy and cancer progression.
Career Highlights
Throughout her career, Xiao-Jun Ma has worked with reputable organizations, including Biotheranostics, Inc. and The General Hospital Corporation. Her expertise in cancer research has positioned her as a leader in the field, contributing to advancements that enhance patient care and treatment options.
Collaborations
Xiao-Jun Ma has collaborated with esteemed colleagues, including Mark G. Erlander and Dennis Sgroi. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of knowledge in cancer research.
Conclusion
Xiao-Jun Ma's contributions to cancer research through her patents and collaborations highlight her dedication to improving diagnostic and treatment methods. Her innovative work continues to pave the way for advancements in the understanding and management of cancer.